Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1134369.RAL5RFCopfgLZXhX0sg4PduQiq8rdibN4LvIANQKxLGb4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1134369.RAL5RFCopfgLZXhX0sg4PduQiq8rdibN4LvIANQKxLGb4130_assertion type Assertion NP1134369.RAL5RFCopfgLZXhX0sg4PduQiq8rdibN4LvIANQKxLGb4130_head.
- NP1134369.RAL5RFCopfgLZXhX0sg4PduQiq8rdibN4LvIANQKxLGb4130_assertion wasGeneratedBy ECO_0000203 NP1134369.RAL5RFCopfgLZXhX0sg4PduQiq8rdibN4LvIANQKxLGb4130_provenance.
- NP1134369.RAL5RFCopfgLZXhX0sg4PduQiq8rdibN4LvIANQKxLGb4130_assertion wasDerivedFrom befree-2016 NP1134369.RAL5RFCopfgLZXhX0sg4PduQiq8rdibN4LvIANQKxLGb4130_provenance.
- NP1134369.RAL5RFCopfgLZXhX0sg4PduQiq8rdibN4LvIANQKxLGb4130_assertion SIO_000772 24311722 NP1134369.RAL5RFCopfgLZXhX0sg4PduQiq8rdibN4LvIANQKxLGb4130_provenance.
- NP1134369.RAL5RFCopfgLZXhX0sg4PduQiq8rdibN4LvIANQKxLGb4130_assertion evidence source_evidence_literature NP1134369.RAL5RFCopfgLZXhX0sg4PduQiq8rdibN4LvIANQKxLGb4130_provenance.
- NP1134369.RAL5RFCopfgLZXhX0sg4PduQiq8rdibN4LvIANQKxLGb4130_assertion description "[Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib in the TCL1 mouse significantly delays the development of CLL, demonstrating that BTK is a critical kinase for CLL development and expansion and thus an important target of ibrutinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1134369.RAL5RFCopfgLZXhX0sg4PduQiq8rdibN4LvIANQKxLGb4130_provenance.